机构：[1]Evidence-Based Medicine Center, School of BasicMedical Sciences, Lanzhou University, Lanzhou, China[2]Research Unit of Evidence-Based Evaluation and Guidelines, Chinese Academy of Medical Sciences (2021RU017), School of BasicMedical Sciences, Lanzhou University, Lanzhou, China[3]Institute of Health Data Science, Lanzhou University, Lanzhou, China[4]Arthritis Clinic & Research Center, Peking University People’s Hospital, Peking University, Beijing, China[5]Department of RespiratoryMedicine Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, China[6]Center for Clinical Epidemiology and Methodology, Guangdong Second Provincial General Hospital, Guangzhou, China[7]School of Public Health, Lanzhou University, Lanzhou, China[8]TheMichael G. DeGroote Institute for Pain Research and Care, McMaster University, Hamilton, Canada[9]Key Research Department of Standardization of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China广东省中医院[10]Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China[11]Chinese Evidence-based Medicine Centre,West China Hospital, Sichuan University, Chengdu, China四川大学华西医院[12]Center for Evidence-Based and Translational Medicine, Zhongnan Hospital ofWuhan University,Wuhan, China[13]School of Public Administration and Policy, Renmin University of China, Beijing, China[14]Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China[15]EditorialOffice of Chinese Journal of Dermatology, Institute of Dermatology, Chinese Academy ofMedical Sciences and Peking UnionMedical College, Nanjing, China[16]China Center for Health Development Studies, Peking University, Beijing, China[17]National Cancer Center/Cancer Hospital, Chinese Academy ofMedical Sciences and Peking UnionMedical College, Beijing, China[18]Department of Ophthalmology, Zhongshan Hospital, Fudan University, Shanghai, China[19]The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China广东省中医院[20]Department of Orthopaedics, Second Hospital of ShanxiMedical University, Taiyuan, China[21]Department of Oncology Surgery, the First Hospital of Lanzhou University, Lanzhou, China[22]School of Nursing, Peking University, Beijing, China
Objective The purpose of the extension of the RIGHT Statement for INTroductions and INTerpretations of Clinical Practice Guidelines (RIGHT for INT) is to promote the development of comprehensive and clear articles that introduce and interpret clinical practice guidelines. Methods The RIGHT for INT checklist was developed following methods recommended by the EQUATOR Network. The development process included three stages. In the first stage, a multidisciplinary team of experts was recruited by email and WeChat and further divided into three groups (a steering group, a consensus group, and a secretariat group); in the second stage, the initial items were collected by literature review and brainstorming; and in the third stage, the final items were formed through a Delphi survey and expert consultation. Results A total of 40 initial items were collected through literature review and brainstorming. A final checklist of 27 items was formed after the Delphi survey and expert consultation. The RIGHT for INT checklist contains items on the following 10 topics: title, abstract, background of guideline interpretation, background of guideline development, guideline development methodology, recommendations, strengths, and limitations, implications for local guidelines and clinical research, dissemination and implementation, and reporting quality. Conclusion The RIGHT for INT checklist provides guidance for guideline interpreters on how to introduce and interpret clinical practice guidelines in a scientific and comprehensive manner.
第一作者机构：[1]Evidence-Based Medicine Center, School of BasicMedical Sciences, Lanzhou University, Lanzhou, China[2]Research Unit of Evidence-Based Evaluation and Guidelines, Chinese Academy of Medical Sciences (2021RU017), School of BasicMedical Sciences, Lanzhou University, Lanzhou, China[3]Institute of Health Data Science, Lanzhou University, Lanzhou, China
共同第一作者：
通讯作者：
通讯机构：[1]Evidence-Based Medicine Center, School of BasicMedical Sciences, Lanzhou University, Lanzhou, China[2]Research Unit of Evidence-Based Evaluation and Guidelines, Chinese Academy of Medical Sciences (2021RU017), School of BasicMedical Sciences, Lanzhou University, Lanzhou, China[3]Institute of Health Data Science, Lanzhou University, Lanzhou, China[11]Chinese Evidence-based Medicine Centre,West China Hospital, Sichuan University, Chengdu, China[*1]Evidence-Based Medicine Center, School of BasicMedical Sciences, Lanzhou University, Lanzhou, China.[*2]Chinese Evidence-based Medicine Centre,West China Hospital, Sichuan University, Chengdu, China
推荐引用方式(GB/T 7714)：
Qi Zhou,Dan Xing,Qinyuan Li,et al.An extension of the RIGHT statement for introductions and interpretations of clinical practice guidelines: RIGHT for INT[J].JOURNAL OF EVIDENCE BASED MEDICINE.2022,15(1):55-63.doi:10.1111/jebm.12466.
APA：
Qi Zhou,Dan Xing,Qinyuan Li,Jingyi Zhang,Xufei Luo...&Du Liang.(2022).An extension of the RIGHT statement for introductions and interpretations of clinical practice guidelines: RIGHT for INT.JOURNAL OF EVIDENCE BASED MEDICINE,15,(1)
MLA：
Qi Zhou,et al."An extension of the RIGHT statement for introductions and interpretations of clinical practice guidelines: RIGHT for INT".JOURNAL OF EVIDENCE BASED MEDICINE 15..1(2022):55-63
